Understanding markets for antimicrobial drugs / Casey Sullivan, Allison Kolbe.

Format:

Book

Author/Creator:

Sullivan, Casey, author.

Kolbe, Allison, author.

Language:

English

Subjects (All):

Anti-infective agents.

Marketing of Health Services.

Physical Description:

1 online resource (1 PDF file (12 pages)) : illustrations

Place of Publication:

Washington, D.C. : U.S. Department of Health and Human Services, ASPE, Assistant Secretary for Planning and Evaluation, Office of Science & Data Policy, 2023.

Summary:

Development of novel antimicrobials has slowed, and the preclinical and clinical pipeline is likely to be insufficient to support current and future patient needs. Despite existing incentives, market challenges limit the revenues that novel antimicrobial drug sponsors can receive, leading smaller developers to struggle financially and larger companies to divest from antimicrobial research and development. Ongoing and future patient access to antimicrobial products can be supported alongside antibiotic stewardship goals through significant additional financial incentives that provide a predictable revenue stream for sponsors, particularly those that are "de-linked" from the volume of product sales.

Contents:

OVERVIEW

ESTIMATING THE BURDEN OF ANTIMICROBIAL RESISTANCE

MARKET RETURNS FOR NOVEL ANTIMICROBIAL DRUGS

MARKET CHALLENGES FOR NOVEL ANTIMICROBIAL DRUG DEVELOPMENT

POLICIES TO ENCOURAGE NEW ANTIMICROBIAL DEVELOPMENT

BALANCING DRUG DEVELOPMENT AND STEWARDSHIP TO COMBAT RESISTANCE

NEXT STEPS.

Notes:

Description based on publisher supplied metadata and other sources.